KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $274.6 million.

  • Idexx Laboratories' Profit After Tax rose 1793.89% to $274.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 1860.76%. This contributed to the annual value of $887.9 million for FY2024, which is 506.78% up from last year.
  • Idexx Laboratories' Profit After Tax amounted to $274.6 million in Q3 2025, which was up 1793.89% from $294.0 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Profit After Tax ranged from a high of $294.0 million in Q2 2025 and a low of $132.0 million during Q2 2022
  • Its 5-year average for Profit After Tax is $208.9 million, with a median of $204.3 million in 2021.
  • As far as peak fluctuations go, Idexx Laboratories' Profit After Tax soared by 8263.57% in 2021, and later plummeted by 3485.93% in 2022.
  • Quarter analysis of 5 years shows Idexx Laboratories' Profit After Tax stood at $162.8 million in 2021, then grew by 5.8% to $172.2 million in 2022, then rose by 12.96% to $194.5 million in 2023, then grew by 11.12% to $216.1 million in 2024, then grew by 27.05% to $274.6 million in 2025.
  • Its Profit After Tax was $274.6 million in Q3 2025, compared to $294.0 million in Q2 2025 and $242.7 million in Q1 2025.